Patents Assigned to Biocopea, Ltd.
  • Pharmaceutical compound
    Patent number: 9056140
    Abstract: Provided is a compound comprising: (a) a first component capable of binding to ER+ cell receptors; and (b) a second component; wherein the second component is a ribosome inactivating toxin and is conjugated to the first component.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: June 16, 2015
    Assignee: Biocopea, Ltd.
    Inventors: Gregory Alan Stoloff, Wilson Romero Caparros-Wanderley
  • Treatment of Viral Infections
    Publication number: 20120283334
    Abstract: The invention provides compositions, medicaments and methods of treatment of viral infections, especially respiratory disorders caused by viral infections. In particular, the invention relates to the treatment of acute viral infections using a range of related 1-phenyl-2-amino ethanol, ethanal, and ethane derivatives.
    Type: Application
    Filed: August 10, 2010
    Publication date: November 8, 2012
    Applicant: Biocopea, Ltd.
    Inventors: John Brew, Robin Mark Bannister, Gregory Alan Soloff, Wilson Capparros Wanderlay, Olga Pleguezuelos Mateo